Invesco S&P MidCap 400 GARP ETF Rating $143.30 -0.67 (-0.47%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco S&P MidCap 400 GARP ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GRPM Aggregate RatingModerate Buy 2.53Holdings in GRPM have an aggregate rating of Moderate Buy based on 361 analyst ratings issued in the past year covering 25 companies (53.8% of the portfolio).GRPM Aggregate Price Target$143.30High Prediction$143.30Average Prediction$143.30Low Prediction$143.30Holdings in GRPM have an aggregate price target of $143.30 and a range of $143.30 to $143.30 covering 25 companies (53.8% of the portfolio).GRPM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco S&P MidCap 400 GARP ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 GRPM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.76%IDCCInterDigital$343.65-0.1%4.4905 of 5 stars3.00$416.67 21.2%5Analyst Downgrade2.69%HALOHalozyme Therapeutics$98.66-2.0%3.8707 of 5 stars2.62$91.20 -7.6%13Insider Trade2.68%ANFAbercrombie & Fitch$108.24-0.5%4.0019 of 5 stars2.62$117.55 8.6%13News CoverageAnalyst UpgradeInsider Trade2.59%DUOLDuolingo$132.83-7.8%3.975 of 5 stars2.09$148.12 11.5%23Analyst Forecast2.55%HLHecla Mining$18.36+3.6%4.2991 of 5 stars2.13$24.13 31.4%8Positive NewsGap Up2.40%KNSLKinsale Capital Group$378.88+0.5%3.1239 of 5 stars1.80$362.11 -4.4%10Dividend AnnouncementAnalyst Revision2.36%SNSharkNinja$184.25-2.3%3.5776 of 5 stars2.92$188.59 2.4%13Analyst ForecastInsider Trade2.35%APPFAppFolio$204.21+0.1%4.2351 of 5 stars3.08$243.50 19.2%12Analyst UpgradeInsider Trade2.26%MEDPMedpace$578.50-0.6%3.5613 of 5 stars2.23$584.18 1.0%13Analyst UpgradeInsider Trade2.25%RNRRenaissanceRe$323.53+1.1%3.8152 of 5 stars2.24$336.33 4.0%17Analyst Revision2.22%PCTYPaylocity$148.28-2.9%3.214 of 5 stars2.71$160.00 7.9%17Analyst Upgrade2.20%FTITechnipFMC$78.63+2.6%3.5864 of 5 stars2.81$69.64 -11.4%16Positive NewsOptions Volume2.14%QLYSQualys$186.05-5.0%2.557 of 5 stars2.35$170.53 -8.3%17Analyst Upgrade2.09%THCTenet Healthcare$267.23+0.1%3.1531 of 5 stars2.95$273.00 2.2%21Analyst UpgradeAnalyst Revision2.00%GMEDGlobus Medical$85.75-0.2%3.7487 of 5 stars2.88$101.77 18.7%171.99%LNTHLantheus$100.95+0.0%3.5208 of 5 stars2.36$108.11 7.1%141.98%HLNEHamilton Lane$104.24-2.8%4.9942 of 5 stars2.89$131.71 26.4%91.95%SLMSLM$28.03+1.0%3.6937 of 5 stars2.33$29.80 6.3%12Positive News1.91%CRSCarpenter Technology$543.90+1.6%3.6392 of 5 stars3.00$577.25 6.1%10Dividend Announcement1.77%DOCSDoximity$24.86-6.5%4.2653 of 5 stars2.28$32.10 29.1%25Analyst ForecastInsider Trade1.77%NBIXNeurocrine Biosciences$152.72+1.3%4.9877 of 5 stars2.88$200.86 31.5%24Analyst Downgrade1.77%DOCUDocusign$62.04-3.2%2.5629 of 5 stars2.11$60.27 -2.9%19Insider Trade1.75%EXELExelixis$51.24+1.2%3.1006 of 5 stars2.32$49.79 -2.8%19Analyst UpgradeInsider Trade1.69%VALValaris$85.73+0.7%2.5214 of 5 stars1.89$60.94 -28.9%91.67%TTEKTetra Tech$36.51+0.2%4.5522 of 5 stars2.60$38.25 4.8%5Positive News This page (NYSEARCA:GRPM) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredOne wafer-scale chip does in minutes what AI takes daysNVIDIA has dominated the AI computing race, but history shows even titans can be dethroned, just ask IBM. T...Eagle Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco S&P MidCap 400 GARP ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco S&P MidCap 400 GARP ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
